In addition, we also compared the activity of NKp46-Fc null-CD123 and CD123-NKCE on CD64-negative and CD64-positive primary sample AML no. 2 and AML no. 4 (Fig. 3b). This evidence concerns the gene NCR1 and acute myeloid leukemia.